Glucagon-like peptide-1 receptor agonists (GLP-1 agonists), such as semaglutide (e.g., Ozempic), have helped improve the management of type 2 diabetes and obesity. However, their use in the perioperative period surrounding major surgeries, like total joint arthroplasty (TJA), remains an area of growing interest and concern.
The Grand Opening is a result of an innovative partnership between Methodist Healthcare, the University of Tennessee Health Science Center, and West Clinic, who joined together in January 2012 to form West Cancer Center.
“This is the first time that such an in-depth survey highlighting the seizure cluster burden of illness has ever been conducted,” said James Wheless, M.D., Professor and Chief, Department of Pediatric Neurology, University of Tennessee Health Science Center.
University of Tennessee Health Science Center professor Dr. Lisa Jennings was honored for the foundation of CirQuest Labs and Ariste Medical. Her multi-service lab connects pharmaceutical and device industries, while reducing costs and complexity.
The American Diabetes Association, the nation’s largest voluntary health organization leading the fight to Stop Diabetes®, is pleased to announce that Samuel Dagogo-Jack, MD, of Memphis TN, has been named President, Medicine & Science of its Board of Directors.
Samuel Dagogo-Jack is Professor of Medicine and Director, Division of Endocrinology, Diabetes and Metabolism, and Director, Clinical Research Center at the University of Tennessee Health Science Center, Memphis, where he holds the A.C. Mullins Endowed Chair in Translational Research.
